SOURCE: Institute for the Study of Aging

August 29, 2005 05:00 ET

Institute for the Study of Aging Sponsors Alzheimer's Drug Discovery Conference

NEW YORK CITY, NY -- (MARKET WIRE) -- August 29, 2005 -- The Institute for the Study of Aging (ISOA), Ltd., a biomedical venture philanthropy founded by the Lauder family, is sponsoring a two-day Alzheimer's Disease Drug Discovery Conference Thursday and Friday, October 6-7, at The Rockefeller University in New York City. Academic and biotechnology industry scientists are welcomed to attend.

The conference will feature 31 leading international experts who will present their most recent findings on Alzheimer's disease drug discovery research. A detailed conference agenda and registration forms are available online at The registration fee is $200/person, which includes breakfasts, lunches, and presentation materials. An optional networking dinner is available on Thursday, October 6th and requires a separate reservation. Seating is limited to 100. The registration deadline is September 16.

This conference is being made possible through generous donations from Acumen Pharmaceuticals, Inc., Elan Pharmaceuticals, Inc., and Merck Research Laboratories. Co-sponsorship opportunities are still available. For more information, please contact Monika Halarewicz at 212-901-8009 or

About the Institute for the Study of Aging (ISOA)

The Institute for the Study of Aging (ISOA) is a biomedical venture philanthropy whose sole mission is to accelerate the discovery and development of new drugs to prevent, treat and cure Alzheimer's disease and related dementias. Since its founding as a private foundation by the Lauder family in 1998, ISOA has awarded over $24.3 million for 144 research programs and conferences at leading academic institutions and biotechnology companies worldwide. In 2004, the Lauder family established a public charity, ISOA, Ltd., to enable individuals, foundations and corporations to partner with the Institute in an effort to raise additional funds and award more grants. For more information, visit, or call Howard Fillit, MD (Executive Director) or Suzanne Grossberg (Director of Development) at 212 935 2402.

Contact Information